Celcuity (CELC) traded down -0.49 % during a 24 hours period ending at 07:34 PM Central Europe on Monday 26th. One Celcuity stock can currently be bought for about USD 66.07 on popular exchanges. Current supply of Celcuity stocks is 48.9 mn. Celcuity has a current market capitalization of USD 3.2 bn and approximately USD 85.8 mn worth of Celcuity was traded on exchanges in the last 24 hours. Since last month end, Celcuity has traded -17.79 % down. Simple moving average of last 200 days is at USD 101.6. The highest price of past 52 weeks was recorded at USD 151.02 on 05/04/2026. 52 weeks low was at USD 53.54 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Renasant (RNST) traded up 0.31 % and now trades at USD 41.79. Current market capitalisation for Renasant is USD 3.8 bn. Renasant has a current price to earnings ratio of 12.5.
Cabot (CBT) traded down -0.73 % and now trades at USD 73.41. Current market capitalisation for Cabot is USD 3.8 bn. Current price/earnings ratio for Cabot is 20.68.
Envista (NVST) traded down -1.54 % and now trades at USD 23.55. Envista has a market capitalisation of USD 3.8 bn. Current price/earnings ratio for Envista is 41.3.
Liquidia (LQDA) traded flat 0 % and now trades at USD 44.34. Liquidia has a market capitalisation of USD 3.8 bn. Current price/earnings ratio for Liquidia is 28.45.
Pulse Biosciences (PLSE) traded up 0.65 % and now trades at USD 52.68. Pulse Biosciences has a market capitalisation of USD 3.8 bn.
About Celcuity
Celcuity Inc. is a clinical-stage biotechnology company based in Minneapolis, United States. The company specializes in the development of targeted therapies for the treatment of multiple solid tumor indications. As a health care industry biotechnology company, Celcuity serves clients in the United States. The company’s website is www.celcuity.com , and it is listed on the Nasdaq stock exchange. The date of its Initial Public Offering (IPO) was September 20, 2017.
